Delivery Order SPE2DB24D2100-SPE2DB26FBAKU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,431.02 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.93 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Duloxetine is a serotonin-norepinephrine reuptake...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count) valued at $2,926.02 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a non-set-aside, competitive basis,...
- The Defense Logistics Agency awarded a $1,170.96 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set for completion by September 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 count) valued at $2,115.10. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was awarded on a competitive basis without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,714.99 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 30 mg capsules (1,000 count) with an ultimate completion date of October 23, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,466.44 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCl DR 60 mg capsules (90-count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Duloxetine is a commonly prescribed serotonin-norepinephrine...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,882.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB26FBAKUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,133.54 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count). This non-compete, firm fixed-price delivery order is set to be completed by October 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, continues to serve as a primary supplier of medications and medical supplies to the Defense Health Agency and military healthcare systems through this comprehensive pharmaceutical support vehicle. Duloxetine, a serotonin-norepinephrine reuptake inhibitor, is commonly used to treat depression, anxiety, and chronic pain conditions in military and veteran populations. This routine delivery order exemplifies the ongoing pharmaceutical supply chain support that AmerisourceBergen provides across multiple therapeutic domains to support federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/23/25 |